Navigation Links
ClinfoSource and California State University, East Bay Jointly Launch On-Line Certificate Program in Clinical Research
Date:8/12/2009

ClinfoSource, a US-based global online training company has partnered with California State University, East Bay to provide a web-based certificate program in clinical research. This program will offer aspiring as well as experienced clinical research professionals a solid and practical understanding of clinical trials conduct and management, pertaining to the drug development process.

San Ramon, CA (PRWEB) August 11, 2009 -- ClinfoSource (www.clinfosource.com), provider of online Good Clinical Practice (GCP) training for clinical research professionals, announced today that it has entered into an agreement with California State University, East Bay (CSUEB) (www.CSUeastbay.edu), to jointly offer a web-based certificate program in clinical research. Named 'Clinical Research Education and Training-Online' or CREAT-e, the program comprises three comprehensive courses in clinical research, encompassing the regulations and guidelines for the conduct and management of clinical trials.

In addition to the online course content, the program includes online discussion forums, web-based seminars and course assignments.

The program is targeted for professionals who are seeking a career in Bio-Pharma and Contract Research Organizations (CROs) as well as for experienced clinical research professionals (CRAs, Project Managers and Clinical Coordinators) who are seeking to refresh and enhance their knowledge of the drug development process.

After the successful introduction as a pilot program in May 2009, the CREAT-e program will be officially launched as a full certificate program in September of this year.

Program Website: Visit

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. UCLA welcomes startup to new incubator space at California NanoSystems Institute
2. GreenHouse Energy, Governor Schwarzenegger Join in Driving the Future of Fueling in California
3. Horizon Therapeutics Selected to Present at InsideVentures Debut Investor Conference March 25-26, Santa Barbara, California
4. California Grants SeqWright License to Operate as a Clinical Laboratory
5. Transgenomic Awarded Clinical Laboratory Certification in California
6. AMPAC Fine Chemicals Receives the California Pollution Prevention Challenge Award Two Consecutive Years
7. Tully-Wihr Company Selects Web-Based Allscripts Electronic Health Record for 100 Northern California Physicians
8. Convey Computer™ Corporation Announces First Customer: University of California, San Diego at SC08 Conference
9. California State Senator Shelia Kuehls Leadership in Stem Cell Debate Praised and Embryonic Stem Cell Profiteers Criticized by Repair Stem Cell Institute Spokesman
10. University of Southern California Receives Cancer Diagnosis System for Detecting Esophageal Dysplasia
11. ALS Therapy Development Institute and California Stem Cell, Inc. Announce Long-Term Scientific Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... British Columbia , March 2, 2015 ... IMLFF), a clinical stage biopharmaceutical company specializing in ... that Craig Schneider , Chief Executive Officer, ... webcast at VirtualInvestorConferences.com. DATE: Thursday, March ... > click the red "register/ watch event now" ...
(Date:3/2/2015)... MENLO PARK, Calif. , March 2, 2015 /PRNewswire/ ... company in the emerging field of regenerative medicine, today ... year 2014 financial and operating results on Tuesday, March ... markets. The Company will host a conference call and ... Eastern / 1:30 p.m. Pacific to discuss the results ...
(Date:3/2/2015)... 2015 Outside GC, the leading provider ... addition of Debbie Casey as a member of the ... space. , Debbie has spent over 20 ... Fresenius Medical Care North America in both legal and ... to work with Outside GC’s growing list of healthcare ...
(Date:2/27/2015)... and SUMMERLAND, British Columbia , ... XON ), a leader in synthetic biology, ... acquire  Okanagan Specialty Fruits (OSF), the pioneering agricultural ... the world,s first non-browning apple. Through the acquisition, Intrexon ... that is more appetizing and convenient for consumers while ...
Breaking Biology Technology:InMed Pharmaceuticals to Present Investor Webcast March 5 2Asterias Biotherapeutics to Report Fourth Quarter and Full Year 2014 Results on March 10, 2015 2Outside GC Expands Healthcare Team 2Intrexon to Acquire Okanagan Specialty Fruits 2Intrexon to Acquire Okanagan Specialty Fruits 3Intrexon to Acquire Okanagan Specialty Fruits 4
... Radiology Group Improves Physician Efficiency and Reduces Duplicative ... ... CHICAGO, Nov. 26 RSNA Booth #5924 -- Compressus ... in Illinois, announced today that ARC has improved physician,efficiency and ...
... Million for Q3 of 2007 versus $5.2 Million ... for Q3 of 2006, -- Gross profit increases 102% ... ... of $12.5 Million of Debt to Equity, BEIJING, Nov. 23 /Xinhua-PRNewswire/ -- China Biopharmaceuticals,Holdings, ...
... and PARIS, Nov. 23 Bristol-,Myers Squibb Company ... reported today,that they are terminating their license agreement ... investigation for the treatment of,advanced or metastatic bladder ... Pierre Fabre Medicament and licensed to Bristol-Myers Squibb,in ...
Cached Biology Technology:Diagnostic Turnaround Improved by 600% Through Interoperability 2Diagnostic Turnaround Improved by 600% Through Interoperability 3Diagnostic Turnaround Improved by 600% Through Interoperability 4China Biopharmaceuticals Holdings Announces Third Quarter 2007 Financial Results 2China Biopharmaceuticals Holdings Announces Third Quarter 2007 Financial Results 3China Biopharmaceuticals Holdings Announces Third Quarter 2007 Financial Results 4China Biopharmaceuticals Holdings Announces Third Quarter 2007 Financial Results 5China Biopharmaceuticals Holdings Announces Third Quarter 2007 Financial Results 6China Biopharmaceuticals Holdings Announces Third Quarter 2007 Financial Results 7
(Date:2/10/2015)... -- Alere Inc. (NYSE: ALR), a global leader in ... quarter ended December 31, 2014. Namal ... said, "We made substantial progress in the fourth ... in rapid diagnostics and delivering against our financial ... early January enabled us to substantially reduce our ...
(Date:2/5/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ... company focused on the growing mobile commerce market, announces ... ) as part of its 2015 marketing and branding ... its new consumer website for Wocketwallet.com earlier this month. ... NXT-ID said, "Our new corporate website naturally showcases our ...
(Date:2/5/2015)... 30, 2015  It is gratifying to see that ... for genomic science as a means to better understand ... treatment.  I was honored to participate in today,s White ... program. Since the 1980s my teams ... the first sequenced genome of a free living organism, ...
Breaking Biology News(10 mins):Alere Inc. Announces Fourth Quarter 2014 Results 2Alere Inc. Announces Fourth Quarter 2014 Results 3Alere Inc. Announces Fourth Quarter 2014 Results 4Alere Inc. Announces Fourth Quarter 2014 Results 5Alere Inc. Announces Fourth Quarter 2014 Results 6Alere Inc. Announces Fourth Quarter 2014 Results 7Alere Inc. Announces Fourth Quarter 2014 Results 8Alere Inc. Announces Fourth Quarter 2014 Results 9Alere Inc. Announces Fourth Quarter 2014 Results 10Alere Inc. Announces Fourth Quarter 2014 Results 11Alere Inc. Announces Fourth Quarter 2014 Results 12Alere Inc. Announces Fourth Quarter 2014 Results 13Alere Inc. Announces Fourth Quarter 2014 Results 14Alere Inc. Announces Fourth Quarter 2014 Results 15Alere Inc. Announces Fourth Quarter 2014 Results 16Alere Inc. Announces Fourth Quarter 2014 Results 17Alere Inc. Announces Fourth Quarter 2014 Results 18Alere Inc. Announces Fourth Quarter 2014 Results 19Alere Inc. Announces Fourth Quarter 2014 Results 20Alere Inc. Announces Fourth Quarter 2014 Results 21Alere Inc. Announces Fourth Quarter 2014 Results 22Alere Inc. Announces Fourth Quarter 2014 Results 23Alere Inc. Announces Fourth Quarter 2014 Results 24Alere Inc. Announces Fourth Quarter 2014 Results 25Alere Inc. Announces Fourth Quarter 2014 Results 26Alere Inc. Announces Fourth Quarter 2014 Results 27Alere Inc. Announces Fourth Quarter 2014 Results 28Alere Inc. Announces Fourth Quarter 2014 Results 29Alere Inc. Announces Fourth Quarter 2014 Results 30Alere Inc. Announces Fourth Quarter 2014 Results 31Alere Inc. Announces Fourth Quarter 2014 Results 32Alere Inc. Announces Fourth Quarter 2014 Results 33Alere Inc. Announces Fourth Quarter 2014 Results 34Alere Inc. Announces Fourth Quarter 2014 Results 35Alere Inc. Announces Fourth Quarter 2014 Results 36
... DALLAS Nov. 12, 2007 Human lung-cancer tumors grown ... treated with a synthetic compound that mimics the action of ... UT Southwestern Medical Center report. The findings, appearing in ... compound might one day be used in targeted therapies for ...
... On September 10, 2007, ConsumerLab.com issued ... contain label amounts of folic acid. One of these ... part of U. S. Pharmacopeias (USP) Dietary Supplement Verification ... to the report, USP studied the verified product to ...
... to stopping Alzheimers disease" A new research study from ... could offer a way to blunt or even prevent ... mice with a protein believed to play a key ... the vaccination showed a significant reduction in the build-up ...
Cached Biology News:Synthetic compound promotes death of lung-cancer cells, tumors 2Synthetic compound promotes death of lung-cancer cells, tumors 3Market testing of dietary supplements and drugs underscores value of USP's public health programs 2An Alzheimer's vaccine? 2An Alzheimer's vaccine? 3
...
...
... monoclonal [198C679.2.1] to Presenilin 2 Alzheimer's ... of the disease carry mutations in the ... precursor protein (APP). These disease-linked mutations result ... of amyloid-beta (main component of amyloid deposits ...
Human Presenilin-2 NTF Affinity Purified Polyclonal Ab...
Biology Products: